Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Pine Tree Bark Reduces Diabetic Microangiopathy
Study published in the September edition of Angiology shows that supplementation with Pycnogenol significantly reduced diabetic microangiopathy (DM).
- Pine Tree Bark Reduces Diabetic Microangiopathy
Study published in the September edition of Angiology shows that supplementation with Pycnogenol significantly reduced diabetic microangiopathy (DM).
- Pine Tree Bark Reduces Diabetic Microangiopathy
Study published in the September edition of Angiology shows that supplementation with Pycnogenol significantly reduced diabetic microangiopathy (DM).
- Pine Tree Bark Reduces Diabetic Microangiopathy
Study published in the September edition of Angiology shows that supplementation with Pycnogenol significantly reduced diabetic microangiopathy (DM).
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Turmeric supplements show promise in treating arthritis
New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response.
- Low folate diets found to increase risk of colorectal cancer
new study by scientists at the MUHC, published in the scientific journal Cancer
Research, has revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer.
- Low folate diets found to increase risk of colorectal cancer
new study by scientists at the MUHC, published in the scientific journal Cancer
Research, has revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer.
- Low folate diets found to increase risk of colorectal cancer
new study by scientists at the MUHC, published in the scientific journal Cancer
Research, has revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer.
- Low folate diets found to increase risk of colorectal cancer
new study by scientists at the MUHC, published in the scientific journal Cancer
Research, has revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer.
- Low folate diets found to increase risk of colorectal cancer
new study by scientists at the MUHC, published in the scientific journal Cancer
Research, has revealed that a low level of folate in our diet increases our risk of
developing colorectal cancer.
- New Study Suggests Plant Sterol-Enriched Chocolate Snack Bars Support Heart Health
Study published in the November issue of the Journal of the American Dietetic Association invoved 67 men and women with elevated cholesterol (> 200 mg/dl total cholesterol) who were randomly assigned to consume either the CocoaVia(R) snack bar twice daily, or a placebo product (matched in its design but formulated without plant sterols) for 6 weeks. At the end of 6 weeks, total cholesterol levels had decreased, on average, by 4.7 percent, and LDL levels, on average, had decreased by 6 percent in the group who regularly consumed the CocoaVia(R) snack bar formulated with plant sterols.
- New Study Suggests Plant Sterol-Enriched Chocolate Snack Bars Support Heart Health
Study published in the November issue of the Journal of the American Dietetic Association invoved 67 men and women with elevated cholesterol (> 200 mg/dl total cholesterol) who were randomly assigned to consume either the CocoaVia(R) snack bar twice daily, or a placebo product (matched in its design but formulated without plant sterols) for 6 weeks. At the end of 6 weeks, total cholesterol levels had decreased, on average, by 4.7 percent, and LDL levels, on average, had decreased by 6 percent in the group who regularly consumed the CocoaVia(R) snack bar formulated with plant sterols.
- New Study Suggests Plant Sterol-Enriched Chocolate Snack Bars Support Heart Health
Study published in the November issue of the Journal of the American Dietetic Association invoved 67 men and women with elevated cholesterol (> 200 mg/dl total cholesterol) who were randomly assigned to consume either the CocoaVia(R) snack bar twice daily, or a placebo product (matched in its design but formulated without plant sterols) for 6 weeks. At the end of 6 weeks, total cholesterol levels had decreased, on average, by 4.7 percent, and LDL levels, on average, had decreased by 6 percent in the group who regularly consumed the CocoaVia(R) snack bar formulated with plant sterols.
- New Study Suggests Plant Sterol-Enriched Chocolate Snack Bars Support Heart Health
Study published in the November issue of the Journal of the American Dietetic Association invoved 67 men and women with elevated cholesterol (> 200 mg/dl total cholesterol) who were randomly assigned to consume either the CocoaVia(R) snack bar twice daily, or a placebo product (matched in its design but formulated without plant sterols) for 6 weeks. At the end of 6 weeks, total cholesterol levels had decreased, on average, by 4.7 percent, and LDL levels, on average, had decreased by 6 percent in the group who regularly consumed the CocoaVia(R) snack bar formulated with plant sterols.
- New Study Suggests Plant Sterol-Enriched Chocolate Snack Bars Support Heart Health
Study published in the November issue of the Journal of the American Dietetic Association invoved 67 men and women with elevated cholesterol (> 200 mg/dl total cholesterol) who were randomly assigned to consume either the CocoaVia(R) snack bar twice daily, or a placebo product (matched in its design but formulated without plant sterols) for 6 weeks. At the end of 6 weeks, total cholesterol levels had decreased, on average, by 4.7 percent, and LDL levels, on average, had decreased by 6 percent in the group who regularly consumed the CocoaVia(R) snack bar formulated with plant sterols.
- Higher level of certain fatty acid associated with lower dementia risk
Individuals who have higher levels of a fatty acid known as docosahexaenoic acid (DHA) in their blood may have a significantly lower risk of developing dementia and Alzheimer's disease.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
This research appears in the first issue for September 2006 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
Graham Devereux, M.D., Ph.D., of the Department of Environmental and Occupational Medicine at the University of Aberdeen in the United Kingdom, and seven associates assessed maternal nutrient and respiratory status in 1,253 mothers and children during a five-year period.
According to the authors, children born to mothers from the lowest quintile of vitamin E intake were over five times more likely to manifest early persistent asthma than children whose mothers were in the highest quintile.
"Our findings suggest that vitamin E has a dual effect on lung function and airway inflammation and that the effects could change at differing periods of prenatal and early life," said Dr. Devereux. "Lung function was associated with early vitamin E exposure independent of atopy, whereas allergic airway inflammation was associated with vitamin E exposure in later pregnancy."
However, the researchers also noted that the airways are fully developed by 16 weeks after conception and, consequently, vitamin E exposure in early pregnancy may be more likely to influence airway function than exposure later in pregnancy.
"The present study suggests that children's own nutrient intake at the age of five does not modify the associations between maternal nutrient intake and respiratory outcomes in the children," said Dr. Devereux.
The study cited vegetable oils (sunflower, rapeseed and corn), margarine, wheat germ, nuts and sunflower seeds as major food sources of vitamin E for mothers in the U.K.
In a prior report on this group of children, the researchers found that two-year-olds whose mothers' vitamin E intake during pregnancy had been relatively low were more likely to wheeze even when they had no cold.
For the previous study, the investigators recruited 2,000 pregnant women at 12 months gestation who were attending area antenatal clinics between 1997 and 1999. Plasma antioxidant concentrations were measured in 1,856 mothers at 12 weeks gestation. In addition, symptom questionnaire data was later obtained for 1,253 children. From that group, 478 children were able to provide a lung function test measurement.
In light of the new findings, the authors concluded that the relationship shown between mothers' vitamin E intake during pregnancy and the respiratory outcomes of their children were likely "underestimates of the true association."
"The results of the present study suggest that dietary modification or supplementation during pregnancy to reduce the likelihood of childhood asthma warrants further investigation," said Dr. Devereux.
The researchers added that vitamin E supplementation in adults with established asthma has not been shown to be of clinical benefit.
###
|